Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality. 2000

M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
University of Athens School of Medicine, Department of Clinical Therapeutics, "Alexandra" Hospital, Athens, Greece.

This study examined the usefulness of 01 and QRS dispersion in the prognosis of patients with advanced congestive heart failure (CHF). One hundred four patients in New York Heart Association functional classes II to IV, with a left ventricular ejection fraction of <35%, and untreated with antiarrhythmic drugs, were followed prospectively. QRS and QT dispersion were defined as the maximum difference in QRS and QT interval duration, respectively, measured on all leads of standard 12-lead electrocardiograms. The end points of the study were non-sudden and sudden cardiac mortality. During an average follow-up of 20 months, there were 13 non-sudden and 10 sudden deaths. The average QRS duration was significantly longer in nonsurvivors than in survivors (125 ¿ 34 vs 113 ¿ 34 ms, respectively, p <0.04). Similar results were obtained with 01 dispersion (95 ¿ 48 ms vs 78 ¿ 31 ms, respectively, p <0.03) and QRS dispersion (54 ¿ 17 ms vs 46 16 ms, respectively, p <0.02). Furthermore, patients who died suddenly had significantly greater QRS dispersion than patients who survived (56 ¿ 13 vs 46 ¿ 16 ms, respectively, p <0.02). In a multivariate analysis, QT and QRS dispersion were both independent predictors of non-sudden cardiac death (p = 0.01 and p = 0.001, respectively), and QRS dispersion was also an independent predictor of sudden cardiac death (p = 0.04). Death rate in patients with 01 dispersion >90 ms was 2.8-fold higher than those with 01 dispersion 90 ms (95% confidence intervals [CI] 1.2 to 6.4). Similarly, the death rate in patients with QRS dispersion >46 ms was 3.9-fold higher than in those with QRS dispersion 46 ms (95% Cl 1.6 to 9.5). These findings suggest that QT and QRS dispersion are useful predictors of mortality in patients with advanced CHF. ¿2000 by Excerpta Medica, Inc.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
February 1994, Lancet (London, England),
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
February 1997, European heart journal,
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
January 2008, The heart surgery forum,
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
June 2002, American heart journal,
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
May 1987, Circulation,
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
November 1991, Journal of clinical pharmacology,
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
April 1992, Pacing and clinical electrophysiology : PACE,
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
July 2001, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc,
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
August 2008, Heart rhythm,
M I Anastasiou-Nana, and J N Nanas, and L A Karagounis, and E P Tsagalou, and G E Alexopoulos, and S Toumanidis, and S Gerali, and S F Stamatelopoulos, and S D Moulopoulos
March 1990, Cardioscience,
Copied contents to your clipboard!